Condition

Sarcoidosis, Pulmonary

ClinicalTrials.gov condition label

Clinical trials3

Recruiting1

Common interventions3

Lead sponsors shown3

Clinical trials

3 shown

Feasibility of Semaglutide in Advanced Lung DiseaseNCT05746039 · 2024-01-29

RECRUITING

A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or SarcoidosisNCT03727451 · 2019-01-30

COMPLETED

Exploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung DiseaseNCT03455686 · 2018-04-19

UNKNOWN

Common interventions

Hyperpolarized 129Xe MRIOTHER1iNOCOMBINATION_PRODUCT1Semaglutide Pen InjectorDRUG1

Leading sponsors

Bellerophon1McMaster University1University of Pennsylvania1

Trial status mix

COMPLETED1

RECRUITING1

UNKNOWN1

Phase mix

PHASE22

NA1

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.